1338481-39-2

Upstream product

• 1338481-38-1 (R)-2-((1R,2R)-1-(benzyloxy)-2-methylbut-3-en-1-yl)-1-((R)-1-phenylethyl)aziridine 
• 3396-11-0 cesium acetate 

Downstream Products

• 1338481-41-6 (2R,3R,4R)-2-(N-methyl-N-((R)-1-phenylethyl)amino)-3-(benzyloxy)-6-hydroxy-4-methylhexyl acetate 
• 1338481-42-7 (2R,3R,4R)-2-(N-methyl-N-((R)-1-phenylethyl)amino)-3-(benzyloxy)-5-formyl-4-methylpentyl acetate 
• 1338481-43-8 (E,2R,3R,4R)-2-(N-methyl-N-((R)-1-phenylethyl)amino)-3-(benzyloxy)-4-methyloct-6-en-1-ol 
• 59865-23-5 (2S,3R,4R,6E)-3-hydroxy-4-methyl-2-methylamino-6-octenoic acid 

Relevant academic research and scientific papers

N-Methylative aziridine ring opening and asymmetric synthesis of MeBmt

Asymmetric synthesis of MeBmt, an unusual amino acid constituent of cyclosporine A, was achieved from aziridine-(2R)-carboxaldehyde through the highly stereoselective addition of (E)-crotylboronate and the subsequent N-methylative aziridine ring opening as key steps.